ArticleCancers2020

Potential of Tyrosine Kinase Receptor TIE-1 as Novel Therapeutic Target in High-PI3K-Expressing Ovarian Cancer.

Xuewei Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.